Solid Biosciences SLDB
NASDAQ SLDB
$6.98 -0.25 (-3.46%)
At close: Oct 1, 2026 · 4:00 PM EDT

Solid Biosciences (SLDB) Cash from Financing Activities (2017 - 2026)

Updated

Solid Biosciences (SLDB) reported Cash from Financing Activities of $48.47 million for Q2 2026, compared with -$1.6 million a year earlier and down 79.7% from the prior quarter.

Analysis

Solid Biosciences (SLDB) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Solid Biosciences' Cash from Financing Activities came in at $293.82 million, up 48.2% year-over-year; for FY2025, it came in at $194.45 million, up 58.8% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $122.44 million in FY2024, $3.12 million in FY2023 (-95.8%), $74.83 million in FY2022 (-44.6%) and $134.99 million in FY2021 (+4.9%).
  • Five-year quarterly Cash from Financing Activities spans a low of -$1.6 million in Q2 2025 and a high of $239.03 million in Q1 2026.
  • Year over year, Cash from Financing Activities gained in two of the last four quarters, with growth averaging 3.3%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $239.03 million (Q1 2026), $5.14 million (Q4 2025) and $1.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Solid Biosciences 1.04 Bn 1.04 Bn - 48.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.47 Mn
Mar 31, 2026 239.03 Mn
Dec 31, 2025 5.14 Mn
Sep 30, 2025 1.18 Mn
Jun 30, 2025 -1.60 Mn
Mar 31, 2025 189.73 Mn
Dec 31, 2024 6.94 Mn
Sep 30, 2024 3.26 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 107.24 Mn
Dec 31, 2023 505,000.00
Dec 31, 2022 74.74 Mn
Sep 30, 2022 -1,000.00
Jun 30, 2022 73,000.00
Mar 31, 2022 22,000.00
Dec 31, 2021 66,000.00
Sep 30, 2021 3,000.00
Jun 30, 2021 -238,000.00
Mar 31, 2021 135.15 Mn
Dec 31, 2019 -287,000.00
API Access

Solid Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SLDB&period=max&api_key=YOUR_API_KEY